Literature DB >> 15357528

[The use of guidelines in the primary care management of hypertension and diabetes].

Nicole Wagner1, David Pittrow, Wilhelm Kirch, Beate Küpper, Petra Krause, Michael Höfler, Peter Bramlage, Hans-Ulrich Wittchen.   

Abstract

OBJECTIVES: The paper examines to what degree German primary care physicians know and work along the rules established in guidelines for arterial hypertension and diabetes mellitus.
METHODS: HYDRA is a 2-stage cross-sectional point prevalence study with 1912 participating primary care settings throughout Germany including 45,125 patients. A pre-study questionnaire to assess doctors practice patterns was used. Subsequently doctors completed a structured clinical appraisal with a diagnostic workup and characterization of the current treatments provided. All patients filled out a questionnaire.
RESULTS: Pre-study results show that only every second primary care physician manages the patients according to established guidelines. Further, physicians estimated their own work as problematic and not always successful. Guideline-oriented doctors were more likely to report hypertension and diabetes treatment patterns that also match guideline's recommendations.
CONCLUSIONS: The study shows a considerable degree of dissatisfaction with the quality of their work among primary care physicians. Guideline-oriented doctors however reveal more frequently formally adequate management characteristics. This encouraging aspect suggests the need of more successful implementation of medical guidelines in order to achieve improved evidence-based medicine and better patient-oriented health care.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15357528     DOI: 10.1007/s00038-004-3063-5

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN: 0303-8408


  2 in total

1.  Diuretics for hypertension-reasons for a contradiction in primary care prescribing behavior: a qualitative study.

Authors:  Henrik Lamers; Stefanie Joos; Katja Goetz; Katja Hermann; Joachim Szecsenyi; Thomas Kühlein
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-07-09       Impact factor: 3.738

2.  Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.

Authors:  Ulrich Kintscher; Peter Bramlage; W Dieter Paar; Martin Thoenes; Thomas Unger
Journal:  Cardiovasc Diabetol       Date:  2007-04-03       Impact factor: 9.951

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.